US 11129810
Dosage regimen for the treatment of acute exacerbations of chronic obstructive pulmonary disease
granted A61KA61K31/415A61K9/0053
Quick answer
US patent 11129810 (Dosage regimen for the treatment of acute exacerbations of chronic obstructive pulmonary disease) held by MEREO BIOPHARMA 1 LIMITED expires Mon Sep 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- MEREO BIOPHARMA 1 LIMITED
- Grant date
- Tue Sep 28 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K31/415, A61K9/0053, A61P, A61P11/00